DIVI'S LABORATORIES LTD.

NSE : DIVISLABBSE : 532488ISIN CODE : INE361B01024Industry : Pharmaceuticals & DrugsHouse : Divis Labs
BSE3726.25-52.95 (-1.4 %)
PREV CLOSE ( ) 3779.20
OPEN PRICE ( ) 3709.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 9941
TODAY'S LOW / HIGH ( )3686.20 3767.10
52 WK LOW / HIGH ( )3050.15 4072.35
NSE3716.00-63.7 (-1.69 %)
PREV CLOSE( ) 3779.70
OPEN PRICE ( ) 3770.00
BID PRICE (QTY) 3715.65 (1)
OFFER PRICE (QTY) 3716.00 (2)
VOLUME 403050
TODAY'S LOW / HIGH( ) 3686.20 3770.00
52 WK LOW / HIGH ( )3051 4074.4
ChairmanRamesh BV Nimmagadda
Managing DirectorMurali K Divi
Company SecretarySatish Choudhury
Executive DirectorN V Ramana
Non Executive Independent DirectorG Suresh Kumar
R Ranga Rao
KVK Seshavataram
S Ganapaty
Sunaina Singh
K V Chowdary
Whole Time DirectorKiran S Divi
Whole Time Director - CommercialNilima Prasad Divi
Registered Office

Address 1-72/23( P)/ Divis/303,Divi Towers, Cyber Hills,Gachibowli Hyderabad,
Telangana-500032 .

Phone 040 66966300

Email  mail@divislabs.com 

Industry Pharmaceuticals & Drugs

Listing BSE,NSE,MCX

Incorporation Year : 12-10 1990
ATTENTION INVESTORSKYCIPO
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :
REGISTRATION NOS.

NSE CM-INZ000234235|NSE F& O - INZ000234235, NSE CD-INZ000234235, BSE CM–INZ000234235 |BSE F & O - INZ000234235|BSE CD- INZ000234235 MCX-SX CM-INZ000234235|MCX-SX F & O - INZ000234235|MCX-SX CD-INZ000234235 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016|SEBI-PMS: INP000007100|LEI- 3358007DLCFNHY8J2F96

Filing compliant on SCORES – Easy & quick

  • Register on SCORES portal
  • Mandatory details for filing complaints on SCORES:
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • Benefits:
    • i.) Effective communication
    • ii.) Speedy redressal of the grievances
INVESTOR PROTECTION

Compliance officer : Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075, E-mail ID: compliance@nnmsecurities.com, cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

"NNM Securities has partnered with TradingView for its charting technology. An investment and trading platform empowering users with global market data and analytical tools like Stock Screener and Economic Calendar."

Copyright © 2021 NNM Securities.com

Advanced Charts Technology Partner: TradingView

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.